Cardio‐microcurrent device for chronic heart failure: first‐in‐human clinical study-Reference-Cited by-同舟云学术

Cardio‐microcurrent device for chronic heart failure: first‐in‐human clinical study

Published:2021-02-09 Issue:2 Volume:8 Page:962-970
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Kosevic Dragana¹,Wiedemann Dominik²^ORCID,Vukovic Petar¹^ORCID,Ristic Velibor¹,Riebandt Julia²^ORCID,Radak Una¹,Brandes Kersten³,Goettel Peter³^ORCID,Duengen Hans‐Dirk⁴,Tahirovic Elvis⁵,Kottmann Tatjana⁶,Voss Hans Werner⁶,Zdravkovic Marija⁷^ORCID,Putnik Svetozar⁸,Schmitto Jan D.⁹,Mueller Johannes³,Rame Jesus Eduardo¹⁰,Peric Miodrag¹

Affiliation:

1. Cardiovascular Institute Dedinje Belgrade Belgrade Serbia

2. Medical University Vienna Vienna Austria

3. Berlin Heals Berlin Germany

4. Charité — Universitätsmedizin Berlin Berlin Germany

5. SciRent Clinical Research and Science Belgrade Serbia

6. Clinical Research Organization Kottmann Hamm Germany

7. University Hospital Medical Center Bezanijska Kosa Belgrade Belgrade Serbia

8. School of Medicine University of Belgrade Belgrade Serbia

9. Hannover Medical School Hannover Germany

10. Advanced Cardiac and Pulmonary Vascular Disease Programs Jefferson Heart Institute Philadelphia PA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13242

Reference49 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America;Yancy CW;Circulation,2013

3. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure

4. Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

5. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microcurrent-Mediated Modulation of Myofibroblasts for Cardiac Repair and Regeneration;International Journal of Molecular Sciences;2024-03-13

2. Digital Technologies to Support Better Outcome and Experience of Care in Patients with Heart Failure;Current Heart Failure Reports;2022-04-29

3. Myocardial Edema Revisited in a New Paradigm of Cardiac Electrical Microcurrent Application in Heart Failure;Bioelectricity;2021-09-01

4. First-in-man Implantation of a Cardiac Microcurrent Device for Chronic Systolic Heart Failure;ASAIO Journal;2021-07-27